Treatment with intravenous immunoglobulins and methylprednisolone may significantly decrease loss of renal function in chronic-active antibody-mediated rejection

Research output: Contribution to journalArticleAcademic

18 Citations (Scopus)
29 Downloads (Pure)
Original languageUndefined/Unknown
Article number218
JournalBMC Nephrology
Volume20
DOIs
Publication statusPublished - 2019

Research programs

  • EMC MM-03-24-01
  • EMC MM-04-39-05

Cite this